Evidence map›Paper›PMID 25043062›Full record

ArticleNature2014

Exonuclease-mediated degradation of nascent RNA silences genes linked to severe malaria.

Qingfeng Zhang, T Nicolai Siegel, Rafael M Martins, Fei Wang, Jun Cao, Qi Gao, Xiu Cheng, Lubin Jiang, Chung-Chau Hon, Christine Scheidig-Benatar and 7 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Nature, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 89 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Resetting var Gene Transcription in Plasmodium falciparum.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 3 countries.

Qingfeng Zhang1] Research Center for Translational Medicine, Shanghai East Hospital and Institute of Infectious Diseases and Vaccine Development, Tongji University School of Medicine, Shanghai 200120, China [2] Unité de Biologie des Interactions Hôte-Parasite, Institut Pasteur, F-75724 Paris, France [3] CNRS, URA 2581, F-75724 Paris, France.
T Nicolai Siegel1] Unité de Biologie des Interactions Hôte-Parasite, Institut Pasteur, F-75724 Paris, France [2] CNRS, URA 2581, F-75724 Paris, France [3] Research Center for Infectious Diseases, University of Würzburg, 97080 Würzburg, Germany.
Rafael M Martins1] Unité de Biologie des Interactions Hôte-Parasite, Institut Pasteur, F-75724 Paris, France [2] CNRS, URA 2581, F-75724 Paris, France.
Fei WangResearch Center for Translational Medicine, Shanghai East Hospital and Institute of Infectious Diseases and Vaccine Development, Tongji University School of Medicine, Shanghai 200120, China.
Jun CaoJiangsu Institute of Parasitic Diseases, Key Laboratory of Parasitic Disease Control and Prevention (Ministry of Health), and Jiangsu Provincial Key Laboratory of Parasite Molecular Biology, Wuxi 214064, China.
Qi GaoJiangsu Institute of Parasitic Diseases, Key Laboratory of Parasitic Disease Control and Prevention (Ministry of Health), and Jiangsu Provincial Key Laboratory of Parasite Molecular Biology, Wuxi 214064, China.
Xiu ChengKey Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China.
Lubin JiangKey Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China.
Chung-Chau HonCell Biology of Parasitism Unit, Institut Pasteur, and INSERM U786, F-75724 Paris, France.
Christine Scheidig-Benatar1] Unité de Biologie des Interactions Hôte-Parasite, Institut Pasteur, F-75724 Paris, France [2] CNRS, URA 2581, F-75724 Paris, France.
Hiroshi Sakamoto1] Unité de Biologie des Interactions Hôte-Parasite, Institut Pasteur, F-75724 Paris, France [2] CNRS, URA 2581, F-75724 Paris, France.
Louise TurnerCentre for Medical Parasitology, Department of International Health, Immunology &Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen and Department of Infectious Diseases, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark.
Anja T R JensenCentre for Medical Parasitology, Department of International Health, Immunology &Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen and Department of Infectious Diseases, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark.
Aurelie Claes1] Unité de Biologie des Interactions Hôte-Parasite, Institut Pasteur, F-75724 Paris, France [2] CNRS, URA 2581, F-75724 Paris, France.
Julien Guizetti1] Unité de Biologie des Interactions Hôte-Parasite, Institut Pasteur, F-75724 Paris, France [2] CNRS, URA 2581, F-75724 Paris, France.
Nicholas A Malmquist1] Unité de Biologie des Interactions Hôte-Parasite, Institut Pasteur, F-75724 Paris, France [2] CNRS, URA 2581, F-75724 Paris, France.
Artur Scherf1] Unité de Biologie des Interactions Hôte-Parasite, Institut Pasteur, F-75724 Paris, France [2] CNRS, URA 2581, F-75724 Paris, France.
Centre National de la Recherche Scientifique · FRInstitut Pasteur · FRInstitut Pasteur of Shanghai · CNJiangsu Institute of Parasitic Diseases · CNShanghai East Hospital · CNCopenhagen University Hospital · DKInserm · FRRigshospitalet · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antigenic variation of the Plasmodium falciparum multicopy var gene family enables parasite evasion of immune destruction by host antibodies. Expression of a particular var subgroup, termed upsA, is linked to the obstruction of blood vessels in the brain and to the pathogenesis of human cerebral malaria. The mechanism determining upsA activation remains unknown. Here we show that an entirely new type of gene silencing mechanism involving an exonuclease-mediated degradation of nascent RNA controls the silencing of genes linked to severe malaria. We identify a novel chromatin-associated exoribonuclease, termed PfRNase II, that controls the silencing of upsA var genes by marking their transcription start site and intron-promoter regions leading to short-lived cryptic RNA. Parasites carrying a deficient PfRNase II gene produce full-length upsA var transcripts and intron-derived antisense long non-coding RNA. The presence of stable upsA var transcripts overcomes monoallelic expression, resulting in the simultaneous expression of both upsA and upsC type PfEMP1 proteins on the surface of individual infected red blood cells. In addition, we observe an inverse relationship between transcript levels of PfRNase II and upsA-type var genes in parasites from severe malaria patients, implying a crucial role of PfRNase II in severe malaria. Our results uncover a previously unknown type of post-transcriptional gene silencing mechanism in malaria parasites with repercussions for other organisms. Additionally, the identification of RNase II as a parasite protein controlling the expression of virulence genes involved in pathogenesis in patients with severe malaria may provide new strategies for reducing malaria mortality.

Indexed as

Gene SilencingAllelesAntigenic VariationChromatinDown-RegulationErythrocytesExoribonucleasesGenes, ProtozoanHumansIntronsMalaria, CerebralMalaria, FalciparumPlasmodium falciparumPromoter Regions, GeneticProtozoan ProteinsRNA, MessengerChromatinexoribonuclease IIExoribonucleasesProtozoan ProteinsRNA, MessengerRNA, ProtozoanRNA, UntranslatedVirulence Factors

Identifiers

PMID25043062
OpenAlexW2094967704

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.